AU676996B2 — Use of aqueous solutions containing peroxobisulphate ions for the treatment of malignant cells
Assigned to Individual · Expires 1997-04-10 · 29y expired
What this patent protects
PCT No. PCT/EP92/02244 Sec. 371 Date Oct. 20, 1994 Sec. 102(e) Date Oct. 20, 1994 PCT Filed Sep. 29, 1992 PCT Pub. No. WO93/14774 PCT Pub. Date Aug. 5, 1993Aqueous solutions containing peroxodisulfate ions are described for the preparation of medicaments for the treatment of mali…
USPTO Abstract
PCT No. PCT/EP92/02244 Sec. 371 Date Oct. 20, 1994 Sec. 102(e) Date Oct. 20, 1994 PCT Filed Sep. 29, 1992 PCT Pub. No. WO93/14774 PCT Pub. Date Aug. 5, 1993Aqueous solutions containing peroxodisulfate ions are described for the preparation of medicaments for the treatment of malignant cells of human and animal bodies. Furthermore, a process for the preparation of the agent and a device for carrying out the process are described. The agents are available, for instance, by actinic irradiation of aqueous solutions containing anions of oxygen acids of sulfur, particularly sulfate ions and/or peroxodisulfate ions, and having a pH-value of from 2 to 7.
Drugs covered by this patent
- Inomax (NITRIC OXIDE) · Vero Biotech Inc
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.